PetMed Express (PETS) received an unsolicited and non-binding acquisition proposal from SilverCape Investments to acquire all of the outstanding shares of the Company for $4 per share in cash, subject ...
Lake Street analyst Ryan Meyers downgraded the rating on Petmed Express (PETS – Research Report) to a Hold today, setting a price target of $3.50. Ryan Meyers has given his Hold rating due to a ...
PetMed Express, Inc. markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. The firm provides treatments for allergies, arthritis, anxiety, ...
DELRAY BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (PETS) (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today provided an update on the status of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results